Related Experiment Video
Updated: Dec 15, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Therapeutic management of nonvalvular atrial fibrillation]
M A Gunawardene1,2,3, J Hartmann4,5,6, M Jularic4,5,6
1Klinik für Kardiologie, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Deutschland. M.gunawardene@asklepios.com.
Insights
Atrial fibrillation (AF) management involves risk stratification for oral anticoagulation (OAC) or left atrial appendage closure. Rhythm control strategies, including catheter ablation (CA), aim to improve quality of life for symptomatic patients.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
Background:
- Atrial fibrillation (AF) is a common cardiac arrhythmia linked to higher mortality.
- Effective, individualized patient treatment is crucial.
Purpose of the Study:
- To outline current management strategies for atrial fibrillation.
- To discuss risk stratification and treatment options including anticoagulation, device implantation, and catheter ablation.
Main Methods:
- Risk stratification to determine oral anticoagulation (OAC) needs.
- Consideration of left atrial appendage closure devices for specific patient groups.
- Rhythm control strategies, including catheter ablation (CA), for symptomatic AF.
Main Results:
- OAC is initiated based on stroke risk.
- Left atrial appendage closure is an alternative for patients with OAC contraindications.
- Catheter ablation (pulmonary vein isolation) shows high success rates for AF freedom (70-80% paroxysmal, 50% persistent) at 1 year.
- CA survival advantage is currently limited to heart failure patients.
Conclusions:
- AF management requires tailored treatment based on risk assessment.
- Catheter ablation is a key rhythm control strategy, primarily for symptomatic relief and quality of life improvement, with proven survival benefits in heart failure patients.
Abstract:
Atrial fibrillation (AF) is the most frequent persistent cardiac arrhythmia and is associated with an increased mortality. Therefore, an effective differential treatment of patients is mandatory. After a risk stratification oral anticoagulation (OAC) should be initiated depending on the individual stroke risk of each patient. Alternatively, in the presence of contraindications for OAC and an increased risk for bleeding and/or stroke, the implantation of a left atrial appendage closure device can be considered. Symptomatic patients should undergo a rhythm control strategy if possible. Based on the risk-benefit considerations, catheter ablation (CA) of AF plays an increasingly important role in establishing long-term medicinal rhythm control. A pulmonary vein isolation can lead to freedom from AF for 1 year in 70-80% of patients with paroxysmal AF (and approximately 50% in persistent AF). So far, a survival advantage of CA could only be shown in patients with heart failure, so that in most cases this is only a symptomatic treatment for improvement in the quality of life.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Myocarditis III: Medical Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

